Related by context. All words. (Click for frequent words.) 74 flurpiridaz F 69 #F FDG 69 florbetaben 68 flavopiridol 68 ^ sup #m 68 riociguat 68 depsipeptide 68 sorafenib Nexavar 68 pharmacodynamic properties 68 teriflunomide 68 pan HDAC inhibitor 68 cediranib 68 fosbretabulin 67 Pertuzumab 67 antitumour activity 67 MGd 67 INCB# [003] 67 fluorodeoxyglucose FDG 66 favorable pharmacokinetic profile 66 Blinatumomab 66 TG# [003] 66 #F AV 66 Annexin V 66 Deforolimus 66 Tyrima 66 Dasatinib 66 annexin V 66 pharmacokinetic interactions 66 Kahalalide F 66 Degarelix 66 delafloxacin 66 Azedra 66 nucleoside analog 66 DAVANAT 66 antiproliferative effects 66 chemopreventive agent 66 OMP #M# 65 CaPre TM 65 orally dosed 65 busulfan 65 pretargeting 65 urography 65 CBLC# 65 PSN# [002] 65 fluorodeoxyglucose 65 Aplidin 65 BAY #-# 65 metaglidasen 65 evaluating tivozanib 65 erlotinib Tarceva ® 65 mTOR inhibitors 65 orally bioavailable 65 monocytic 65 myocardial perfusion imaging 65 plasma kallikrein inhibitor 65 LY# [003] 65 radiolabeled 65 AEG# 65 mCi 65 ENMD # 65 Alocrest 65 Sapacitabine 65 anti amnesic 65 XmAb# 65 hA# 65 antiangiogenic therapy 65 PET tracers 65 ganetespib 65 PRTX 65 histone deacetylase inhibitor 65 biodistribution 64 immunomodulatory properties 64 Gleevec resistant 64 galiximab 64 fluorodeoxyglucose positron emission tomography 64 BMS # 64 preclinically 64 vorinostat 64 azacytidine 64 Sym# 64 potent antiproliferative 64 CRLX# 64 dose proportionality 64 YONDELIS 64 pomalidomide 64 GRASPA ® 64 vitro experiments 64 PROCHYMAL 64 ALA PDT 64 renal cell carcinomas 64 ritonavir boosted 64 LT NS# 64 Carfilzomib 64 liposomal doxorubicin 64 Aflibercept 64 pharmacodynamic effects 64 selective agonist 64 radiation dosimetry 64 superficial bladder cancer 64 pegylated liposomal doxorubicin 64 Xanafide 64 caspofungin 64 interleukin IL -# 64 #F FDG PET 64 PET tracer 64 oral prodrug 64 radiation sensitizer 64 Teriflunomide 64 antitumor effect 64 glutamyl 64 solithromycin 64 radezolid 64 prostate cancer PCa 64 selective inhibition 64 liposomal amphotericin B 64 LSI #P 64 treat benign prostatic 64 selective antagonist 63 neratinib 63 histone deacetylase inhibitors 63 CA4P 63 CLORETAZINE TM VNP#M 63 proteasome inhibitor bortezomib 63 Nilotinib 63 pertuzumab 63 trans retinoic acid 63 annexin 63 Ophena TM 63 PSMA ADC 63 FDG PET imaging 63 radiotracer 63 iodixanol 63 varespladib 63 tumorigenicity 63 Zysolin TM 63 vascular disrupting agents 63 HuMax EGFr 63 immunohistochemical 63 malignant ascites 63 thalidomide Thalomid 63 proteasome inhibitor 63 tigecycline 63 PKC# 63 relapsed MM 63 F FDG PET 63 paricalcitol 63 SRT# [003] 63 epithelial tumors 63 GW# [003] 63 CTAP# Capsules 63 FDG uptake 63 Bezielle 63 liposomal formulation 63 GFT# 63 DOXIL 63 JAK inhibitor 63 Enzastaurin 63 cariprazine 63 inhibitor RG# 63 demonstrated antitumor activity 63 Pemetrexed 63 PBMCs 63 Anticalins ® 63 TNFa 63 ESBA# 63 AST ALT 63 selective modulator 63 recurrent glioblastoma multiforme 63 Methylnaltrexone 63 LY# [002] 63 colorectal carcinoma 63 Ceflatonin 63 mertansine 63 RAV# 63 antifibrotic 63 OHR/AVR# 63 Liposomal 63 JAK2 inhibitor 63 chemotherapeutic drug 63 5alpha reductase 63 Doxil ® 63 cytostatic 63 preclinical efficacy 63 unresectable tumors 63 tumor hypoxia 63 bortezomib Velcade ® 63 mapatumumab 63 VAPRISOL 63 #beta 63 5 HT6 receptor 63 Tarvacin 63 Squalamine 63 antimitotic 63 intravesical instillation 63 Antiangiogenic 63 PI3K inhibitors 63 Muraglitazar 63 ^ Tc 63 uricase 63 5 Fluorouracil 63 xenograft models 63 NATRECOR ® 63 CDK inhibitor 62 HMG CoA reductase inhibitors 62 nanomolar 62 anticancer agent 62 enzastaurin 62 FK# 62 gadolinium enhanced 62 Aplidin R 62 AMN# [001] 62 immune modulating 62 denileukin diftitox 62 CYT# potent vascular disrupting 62 Vidaza azacitidine 62 indibulin 62 CR# vcMMAE 62 Fenretinide 62 human microdosing 62 radiotracers 62 triphendiol 62 gemcitabine Gemzar 62 stable nucleic acid 62 TAKSTA 62 tanespimycin 62 Subgroup analysis 62 bevacizumab Avastin ® 62 dasatinib Sprycel 62 metastatic neuroendocrine tumors 62 Taxol ® 62 Elotuzumab 62 HIF PH inhibitors 62 Trandolapril 62 ALB # 62 mimetic peptide 62 prucalopride 62 effector function 62 multitargeted 62 receptor tyrosine kinase inhibitor 62 candesartan cilexetil 62 Cytotoxic 62 β blockers 62 myelofibrosis polycythemia vera 62 gefitinib Iressa 62 antiangiogenic agent 62 FDG-PET/CT 62 meropenem 62 vitro cytotoxicity 62 somatostatin receptors 62 Darinaparsin 62 cytoprotective 62 5 HT4 receptor 62 somatostatin receptor 62 pharmacokinetic PK study 62 ALK inhibitors 62 CANCIDAS 62 E. faecalis 62 Gefitinib 62 trabectedin 62 HDACi 62 beta interferons 62 renal tumors 62 radiolabeled monoclonal antibody 62 Epratuzumab 62 gastric adenocarcinoma 62 scintigraphic 62 Florbetapir 62 masitinib 62 imatinib Gleevec 62 zoledronate 62 platelet inhibitor 62 antifolates 62 OXi# 62 HGS# 62 benfotiamine 62 Safinamide 62 EOquin TM 62 micafungin 62 antitumor efficacy 62 peptidic 62 follicular lymphomas 62 alpha 2a 62 sodium glucose cotransporter 62 CIN2 + 62 Cloretazine 62 immunohistochemical analysis 62 PET imaging 62 Interferon alpha 62 diarrhea predominant irritable 62 KB# [002] 62 dexamethasone Decadron 62 ibritumomab tiuxetan 62 decitabine 62 PEG SN# 62 GLYX 62 anticancer activity 62 cilengitide 62 Phase 1b trial 62 PEG IFN 62 idarubicin 62 CCX# 62 HCV SPRINT 62 p# biomarker 62 Aurora Kinase 62 cardiac troponin T 62 IFN beta 62 compound AEZS 62 p# inhibitor 62 cetuximab Erbitux R 62 RLY# 62 targeted antifolate 62 Hsp# Inhibitor 62 TNF Tumor Necrosis Factor 62 A3 adenosine receptor 62 DNA intercalator 62 alkylating agent 62 ibandronate 62 isoproterenol 62 INT# [002] 62 Protelos 62 antiangiogenesis 62 beta2 agonist 62 trastuzumab Herceptin ® 61 PDE4 inhibitor 61 brivaracetam 61 colorectal liver metastases 61 bortezomib Velcade R 61 Traficet EN 61 proteomic analysis 61 Bevirimat 61 preferentially bind 61 Factor VIIa 61 highly selective inhibitor 61 small molecule activators 61 microtubule targeting 61 milatuzumab 61 TACI Ig 61 Cytochrome P# 61 BrachySil TM 61 apolipoproteins 61 ALDH br cells 61 HSP# inhibitor 61 pharmacologic stress 61 XYOTAX TM 61 Erlotinib 61 anti leukemic 61 monoclonal antibody mAb 61 Beta catenin pathway 61 EP #R 61 APOPTONE 61 tolvaptan 61 deoxy 61 Onconase 61 Mitomycin C 61 NOD SCID mice 61 nanopharmaceutical 61 luteinizing hormone releasing 61 LHRH agonists 61 HuMax CD4 61 ATL/TV# 61 pharmacodynamic parameters 61 Solorel TM 61 midkine 61 Fulvestrant 61 bioavailable testosterone 61 Myocardial Perfusion Imaging 61 syngeneic 61 PC# cells 61 PLX cells 61 F FLT 61 Symadex 61 HGS ETR1 61 rhIGFBP 3 61 prostate cancer CaP 61 Tocilizumab 61 alefacept 61 Zybrestat 61 analgesic efficacy 61 BAL# [002] 61 Litx 61 radioligand 61 viral kinetics 61 Immunohistochemical analysis 61 anticancer compound 61 Trofex 61 HQK 61 bone scintigraphy 61 TRAIL R2 61 Naive Patients 61 inecalcitol 61 retapamulin 61 Magnetic resonance 61 docetaxel Taxotere ® 61 Aclidinium 61 lomitapide 61 endothelin receptor 61 Pharmacokinetic studies 61 eosinophil count 61 BRAF V#E mutation 61 elotuzumab 61 #m Tc 61 Archexin 61 cannabinor 61 Antiviral Therapy 61 farletuzumab 61 novel peptide 61 huC# DM4 61 mecamylamine 61 Panzem R NCD 61 hepatoma 61 Vidofludimus 61 Temsirolimus 61 Phase Ib study 61 AKT inhibitor 61 NR2B selective 61 Thiovir 61 S/GSK# 61 alvespimycin 61 azacitidine 61 Estrogen Receptor 61 bexarotene 61 tipranavir 61 #mTc 61 histone deacetylase HDAC inhibitor 61 adult mesenchymal stem 61 systemic antifungal 61 Immunohistochemical staining 61 Antitumor Activity 61 HCV replicon 61 PS# [001] 61 TRAIL R1 61 pyrimidines 61 Irinotecan 61 Anti Tumor 61 murine model 61 Histological examination 61 bezafibrate 61 sunitinib Sutent ® 61 tumor subtypes 61 small molecule activator 61 BSGI MBI 61 ALTROPANE 61 Pharmacodynamics 61 Bortezomib 61 liposome formulation 61 prostate carcinoma 61 ELACYT 61 EpCAM 61 VA# [002] 61 immunoconjugate 61 imatinib Gleevec ® 61 mucinous 61 mycophenolate mofetil 61 NXL# 61 HER2 positive metastatic breast 61 elastase 61 photosensitizer 61 mitomycin 61 Myocet 61 Kinase Inhibitor 61 vidofludimus 61 CCR9 61 Multiple Myeloma MM 61 polycythemia vera PV 61 HER2 antibody 61 radiotherapeutic 61 molecularly targeted 61 AVI NEUGENE 61 lenalidomide dexamethasone 61 Cannabinor 61 oral FTY# 61 deoxyglucose 61 neuroprotective properties 61 sitaxsentan 61 MAb 61 PRT# 61 leukemia AML 61 davunetide intranasal AL 61 retinoid 61 drug zotarolimus 61 pharmacokinetic characteristics 61 plasma pharmacokinetics 61 bovine thrombin 61 APTIVUS 61 Positron Emission Tomography PET 61 bleomycin 61 engineered RAP peptides 61 immunomodulating 61 Voreloxin 61 antiarrhythmic 61 Cytotoxicity 61 phase IIa clinical 61 edifoligide 60 CA9 SCAN 60 prostate cancer AIPC 60 F FDG 60 triiodothyronine 60 stratifying patients 60 atypical hemolytic uremic syndrome 60 targeted radiotherapeutic 60 INC# 60 immunostaining 60 vinca alkaloid 60 SGLT 60 Valopicitabine 60 CIMZIA TM certolizumab pegol 60 prognostic indicator 60 PEGylated interferon 60 selective kinase inhibitor 60 HGS ETR2 60 immunomodulatory agents 60 INCB# [001] 60 Toxicities 60 ovarian carcinoma 60 Angiotensin Converting Enzyme 60 CCR2 60 pharmacodynamic PD 60 EOquin 60 afamelanotide 60 tubulin inhibitor 60 miRview mets 60 Imaging BSGI 60 Cardiotoxicity 60 Fc fusion protein 60 B7 H3 60 Omacetaxine 60 Xelox 60 Capecitabine 60 sorafenib Nexavar ® 60 bladder carcinoma 60 lexidronam injection 60 oral antiviral 60 colorectal adenocarcinoma 60 plus DOXIL 60 BFPET 60 oxysterols 60 molecular biomarkers 60 metastatic malignant 60 anti CD3 60 PI3K inhibitor 60 Pharmacokinetics PK 60 dopamine D2 60 antisense inhibitors 60 Romidepsin 60 angiogenesis inhibition 60 Telbivudine 60 pancreatic adenocarcinoma 60 colony stimulating factor 60 photodynamic therapy PDT 60 T1 weighted images 60 FDG PET 60 SPECT imaging 60 NOD mouse 60 therapeutic monoclonal antibody 60 nanocarrier 60 rosuvastatin Crestor 60 mediated inhibition 60 RRM1 60 Proxinium TM 60 direct thrombin inhibitors 60 myo inositol 60 QTc prolongation 60 cardiac perfusion 60 seliciclib 60 somatostatin analogue 60 trastuzumab Herceptin R 60 tumor xenografts 60 Pharmacokinetic PK 60 Monoclonal 60 Interferon Gamma 60 biodistribution studies 60 intranasal formulation 60 Gleevec imatinib 60 DXL# 60 HCV protease 60 fosamprenavir 60 immunohistochemical staining 60 GSK# [001] 60 AEGR 60 Antiviral Activity 60 Raltegravir 60 PXD# 60 immunomodulator 60 Janus Kinase 60 proteasome inhibitors 60 antidiabetic 60 SSc 60 Mg Uk 60 pyridostigmine 60 PDGF B 60 Phase Ib II 60 See CLINICAL PHARMACOLOGY 60 spiral computed tomography 60 immunoblotting 60 chimeric monoclonal antibody 60 aripiprazole Abilify 60 torezolid 60 perfusion imaging 60 pharmacokinetic parameters 60 Phase Ib clinical 60 metabolomic profiles 60 transgenic mouse models 60 LHRH receptor positive 60 abacavir lamivudine 60 VEGF receptor 60 polymerase inhibitor 60 sCD# 60 cTnI 60 Trastuzumab 60 tolerability profiles 60 LRP6 60 Cloretazine R VNP#M 60 tipifarnib 60 PhG alpha 1 60 Sphingomab 60 Panzem 60 NEUGENE 60 scintigraphy 60 RE LY trial 60 cytotoxicity assays 60 vesicular monoamine transporter 60 pharmacokinetic profiles 60 RG# [001] 60 abacavir Ziagen 60 hPAM4 60 synthetic analogues 60 GAP #B# 60 kinase inhibition 60 TRV# [001] 60 microdose 60 PI3K/mTOR 60 myocardial perfusion 60 retaspimycin 60 bortezomib Velcade 60 Rigel R# 60 M1 muscarinic 60 HDAC Inhibitor 60 axitinib 60 Telintra 60 isoenzyme 60 prostanoid 60 lymphoma subtypes 60 LB# [003] 60 Luteinizing Hormone Releasing Hormone 60 murine models 60 interleukin IL 60 IFN α 60 mTOR inhibitor 60 paclitaxel Taxol 60 MTT assay 60 vinorelbine tartrate 60 redox active 60 NMDA antagonists 60 Dalbavancin 60 liposome injection 60 null responder 60 HIF PHI 60 hepatocellular carcinomas 60 hyperphenylalaninemia HPA due 60 Tyrosine Kinase Inhibitor 60 DCCR 60 naturally occurring molecule 60 GAMMAGARD 60 serum biomarkers 60 MEK inhibitors 60 Protein Kinase C 60 EBUS FNA 60 metastatic gastric 60 ADAGIO study 60 T1 weighted 60 novel VDA molecule 60 Denufosol 60 multicentre randomized 60 NIC5 60 bronchoalveolar lavage 60 ara C 60 thyrotropin 60 soluble CD# ligand 60 transgene expression 60 μmol L 60 receptor antagonists 60 Melphalan 60 ISIS # 60 RSD# 60 efavirenz EFV 60 Tamibarotene 60 computed tomography SPECT 60 urothelial cancer 60 radiotherapy RT 60 rat hepatocytes 60 adipiplon 60 Capesaris 60 Myelodysplastic Syndrome MDS 60 Atiprimod 60 antitumor effects 60 sarcosine 60 peroxidase 60 chondroitin sulphate 60 Estradiol 60 colon carcinoma 60 BAL# [001] 59 octreotide acetate 59 Radezolid 59 Vincristine 59 highly immunogenic 59 posaconazole 59 diagnostic biomarker 59 EUS FNA 59 Genz # 59 Pharmacokinetic 59 talabostat 59 Amrubicin 59 thiazolidinedione TZD 59 carcinoembryonic antigen 59 TGF beta1 59 Aptamer 59 radioimmunoassay 59 mixed hyperlipidemia 59 pharmacodynamic profile 59 cyclophilin inhibitor 59 sclerosing 59 HER1 59 alkaline phosphatase ALP 59 acne vulgaris 59 recurrent GBM 59 eprotirome 59 combretastatin A4 phosphate CA4P 59 muscarinic 59 gastrointestinal stromal tumors GIST 59 Etoposide 59 cytokeratin 59 Cyclin E 59 Allogeneic 59 Photodynamic therapy 59 BN# [004] 59 Zolinza 59 Preclinical Study 59 ARIKACE 59 pDCs 59 serum urate levels 59 Alkaline Phosphatase 59 rFIXFc 59 antiepileptics 59 oral antidiabetic 59 VitiGam 59 hepatic fibrosis 59 prognostic significance 59 ON #.Na 59 ELISPOT 59 tipranavir r 59 cisplatin resistant 59 Oritavancin 59 chemotherapeutic regimen 59 oral JAK1 59 angiotensin receptor blocker ARB 59 Tumor Necrosis Factor 59 Sipuleucel T 59 TIMP 1 59 Epidermal Growth Factor Receptor 59 Apoptone 59 Tarvacin TM 59 amyloid imaging 59 agonism 59 Zavesca R 59 vivo potency 59 IMP# 59 Neuradiab 59 murine monoclonal antibody 59 mouse xenograft models 59 lesional 59 QuadraSphere 59 antiviral efficacy 59 Tumor Response 59 Vaprisol 59 Phase 1b clinical trials 59 sestamibi 59 #F fluorodeoxyglucose 59 bispecific antibody 59 PROSTASCINT 59 gamma secretase inhibitors 59 Lubiprostone 59 GRNCM1 59 receptor blocker 59 bronchial epithelial cells 59 Leydig cell 59 idebenone 59 DU #b 59 CD# expressing 59 serum TSH 59 multikinase inhibitor 59 docetaxel Taxotere R 59 Elvitegravir 59 cisplatin gemcitabine 59 HuMax CD# 59 tocilizumab 59 sunitinib malate 59 FUSILEV enhances 59 TO AVOID PREGNANCY WHILE 59 recurrent glioma 59 Optical coherence tomography 59 trodusquemine 59 receptor inhibitor 59 safety tolerability pharmacokinetic 59 abatacept Orencia 59 anti angiogenic therapy 59 magnetic resonance spectroscopy MRS 59 Radiation Therapy SIRT 59 Kinoid 59 Natalizumab 59 olmesartan 59 benzimidazole 59 Mucosal 59 Guanilib 59 SERCA2a 59 HGPIN 59 Lp PLA2 59 HCV RESPOND 2 59 Sudhir Agrawal D.Phil 59 Combidex 59 urocortin 2 59 GORE TAG Device 59 pDC 59 DermaVir Patch 59 MP4OX 59 verteporfin 59 peritoneal carcinomatosis 59 vimentin 59 elacytarabine 59 IGFBP 3 59 clevidipine 59 Neoadjuvant 59 Lenalidomide 59 cleavable linker 59 Cannabinoid 59 crizotinib PF # 59 LEUKINE 59 TNF α 59 Decitabine 59 protease inhibitor PI 59 LAF# 59 gamma tocotrienol 59 romidepsin 59 YONDELIS R 59 metastatic renal cell carcinoma 59 HER2 overexpression 59 CEQ# 59 arbaclofen 59 teriparatide 59 oral rivaroxaban 59 leiomyomas 59 MBq 59 Neulasta ® 59 IRX 2 59 KRN# 59 investigational monoclonal antibody 59 Aptivus ® 59 TAXUS Stent 59 Epirubicin 59 paclitaxel poliglumex 59 Glatiramer acetate 59 Leydig cells 59 Relivar 59 LJ# [002] 59 antitumoral 59 cetuximab Erbitux 59 Valortim R 59 JAK Inhibitor 59 APTIVUS r 59 diagnostic modality 59 potency selectivity 59 IgG1 antibody 59 thapsigargin 59 positron emission tomography scans 59 L asparaginase 59 Perifosine 59 Adult Stem Cell Therapy 59 gemcitabine Gemzar ® 59 Locked Nucleic Acid LNA 59 cytokine refractory 59 recurrent glioblastoma 59 SCIg 59 EGFR HER2 59 tumor biopsies 59 P selectin 59 Tarceva TM 59 lanthanum carbonate 59 T#I [002] 59 isoprostane 59 JAK2 inhibitors 59 RQ PCR 59 concurrent chemoradiation 59 CG# [003] 59 humanized monoclonal 59 Confocal microscopy 59 Computed tomography 59 dyslipidaemia 59 natriuretic peptides 59 HER3 59 EndoTAG TM -1 59 activin 59 Bendavia 59 non nucleoside 59 thrombin receptor 59 neuroprotective effects 59 NovoTTF 59 bendamustine 59 IAP inhibitor 59 D aspartate NMDA receptor 59 antidepressant efficacy 59 MLN# 59 Immunomodulatory 59 kidney urologic 59 Alphanate R 59 Immunotherapeutic 59 xenograft 59 Cloretazine ® 59 IGF IR 59 virus HCV protease inhibitor 59 Vidaza ® 59 TGF alpha 59 ALK inhibitor 59 peripheral blood mononuclear 59 Nucleoside 59 tumor specific antigen 59 Imprime PGG 59 Debio 59 epothilone 59 HepG2 cells 59 multimodality imaging 59 Receptor Antagonists 59 Aethlon Hemopurifier R 59 Pathway Inhibitor 59 biophysical techniques 59 interleukin IL -6 59 receptor blockers 59 adrenomedullin 59 investigational molecular imaging 59 granisetron 59 nucleoside analogue 59 potent anti angiogenic 59 DCE MRI 59 grade cervical intraepithelial 59 percutaneous biopsy 59 docetaxel chemotherapy 59 NMIBC 59 carcinoid 59 Tigecycline 59 tricalcium phosphate 59 hMG 59 Nanobody 59 NSCLC tumors 59 Peginterferon 59 neoadjuvant treatment 59 Sjögren syndrome 59 quinolone 59 DNA methylation markers 59 ceftazidime 59 plasma lipid 59 galectin 59 peptide BNP 59 ErbB2 positive 59 thyroglobulin 59 HER2 ErbB2 58 systemic bioavailability 58 nucleoside 58 bone marrow progenitor cells 58 metastatic colorectal 58 GMX# 58 glioblastoma multiforme GBM 58 peginterferon alpha 2a 58 Histologic 58 Zemiva 58 interferon alfa 58 rituximab Rituxan 58 AZILECT ® 58 delta isoform 58 pharmacodynamic 58 Letairis ambrisentan 58 calcium antagonists 58 mediated apoptosis 58 microglial 58 eTag assays 58 selectively inhibited 58 μg ml 58 Parathyroid Hormone 58 synthetic siRNA 58 velafermin 58 maximally tolerated dose 58 R#/MEM # 58 MR spectroscopy 58 Lp PLA 2 58 cathepsin B 58 Superoxide 58 selective androgen receptor modulator 58 antagomirs 58 benign neoplasms 58 TTR gene 58 tumor histology 58 PiB PET